Correlation Between Aquestive Therapeutics and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Neurocrine Biosciences, you can compare the effects of market volatilities on Aquestive Therapeutics and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Neurocrine Biosciences.
Diversification Opportunities for Aquestive Therapeutics and Neurocrine Biosciences
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aquestive and Neurocrine is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Neurocrine Biosciences
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Neurocrine Biosciences. In addition to that, Aquestive Therapeutics is 2.55 times more volatile than Neurocrine Biosciences. It trades about -0.04 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.34 per unit of volatility. If you would invest 13,871 in Neurocrine Biosciences on November 9, 2024 and sell it today you would earn a total of 1,180 from holding Neurocrine Biosciences or generate 8.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Neurocrine Biosciences
Performance |
| Timeline |
| Aquestive Therapeutics |
| Neurocrine Biosciences |
Aquestive Therapeutics and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Neurocrine Biosciences
The main advantage of trading using opposite Aquestive Therapeutics and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |